HRT After Hysterectomy/Oophorectomy: What You Need to Know

bek635
Nov 19, 2025
6 min read

Woman in her 30s recovering from hysterectomy and oophorectomy, considering HRT options for surgical menopause — Hrt After Hysterectomy: What you need to know

Quick Takeaways:

· 40% of endometriosis patients skip HRT after hysterectomy/oophorectomy

· Endometriosis recurrence with HRT is only 3.5% (0.9% per year)

· Transdermal estrogen is safer than oral (lower blood clot risk)

· Estrogen-only therapy actually decreases breast cancer risk post-hysterectomy

· Age-appropriate dosing matters—don’t accept elderly-woman doses

The Uncomfortable Truth

40% of endometriosis patients don’t take HRT after hysterectomy or oophorectomy—even when entering surgical menopause. [1]

Why? Fear. Confusion. Lack of clear guidance. And a lot of misinformation about what’s actually safe.

Let me tell you my story.

My Story: Two Years Lost

Right after my hysterectomy and oophorectomy, I was referred to an endocrinologist who prescribed me HRT that would have been suitable for an elderly woman.

Not a woman in her 30s or 40s entering surgical menopause. An elderly woman.

For two years, I advocated for myself. I asked for dose adjustments. I explained my symptoms. And for two years, she failed to research what appropriate HRT dosing would actually look like for someone my age. She just… didn’t care enough to find out.

So I gave up on her and found a different hormone specialist.

Within weeks, I had HRT doses that were life changing.

The Real Problem: Fear-Based Medicine

Here’s what I’ve come to understand: there’s a generation of healthcare providers in positions of power who got lost in the media hype surrounding the Women’s Health Initiative study—a study whose findings have been re-analysed and corrected multiple times, showing that estrogen-only therapy (for women with prior hysterectomy) actually decreases breast cancer incidence and mortality. [2]

And yet they’re so committed to believing that fearful rhetoric that they continue to advocate strongly against HRT for women with a history of endometriosis.

These providers are in positions of power. And they’re making decisions that affect real women’s lives.

What Surgical Menopause Actually Feels Like (Without Adequate HRT)

Imagine being transplanted into a body you don’t recognize. Your metabolism seems faulty, you can’t sleep, and you are so hot.

Imagine a brain that is no longer comfortable in your own skull. It’s like anxiety has formed a tag team with irritability and they are now the CEOs of the board.

Imagine having life-saving surgery—surgery that was necessary, surgery that was right—and then being told you have to sacrifice your quality of life because the healthcare system is too afraid to give you adequate hormone support.

I wouldn’t wish that experience on my worst enemy.

Why People Avoid HRT After Endo Surgery

Woman struggling with HRT decisions after hysterectomy due to lack of clear medical guidance and outdated information — 40% skip HRT due to Fear or Mis-information

The reasons are understandable:

· Fear of endometriosis reactivation – “Will it come back?”

· Cancer risk concerns – “Will HRT give me cancer?” (based on outdated, disproven research)

· Lack of clear clinical guidance – “My doctor won’t help me”

· Inadequate counselling – “Nobody explained the actual risks vs. benefits”

These fears are real. But they’re often based on incomplete or outdated information—information that some providers are still clinging to.

What the Evidence Actually Shows

Evidence-based statistics showing low endometriosis recurrence rate and decreased breast cancer risk with HRT after hysterectomy — HRT is safer than you think

Post-bilateral oophorectomy + HRT recurrence rate: 3.5% (or 0.9% per year) [3,4]

That’s low. That’s manageable. That’s worth discussing with your healthcare provider.

The breast cancer risk? The evidence doesn’t support the fear. In fact, estrogen-only therapy has been shown to decrease breast cancer risk in women who have had hysterectomies. [2] But the fear persists.

The Recommended HRT Approach for Younger Women

Estrogen: Go Transdermal

Transdermal estrogen (patch or gel delivery) is superior to oral estrogen because:

· Avoids first-pass hepatic metabolism (your liver processes less of it)

· Lower thrombotic risk (blood clot risk) [5,6]

· More stable hormone delivery (no peaks and troughs)

Recommended dose: 17β-estradiol patch 0.1–0.15mg/day

Research shows oral estrogen increases venous thromboembolism (VTE) risk by 63%, while transdermal estrogen shows minimal to no increased risk. [5,6]

Transdermal estrogen patch for HRT after hysterectomy, showing safer hormone delivery method with lower blood clot risk

Progesterone: Choose Wisely

Micronized progesterone (preferred): - Natural form - Lower endometriosis reactivation risk - Safer for breast tissue than synthetic progestins [7,8] - Better safety profile overall

Dydrogesterone (alternative): - Synthetic progestin - Good safety profile - Still lower risk than other synthetics

Avoid: Synthetic progestins (higher endometriosis reactivation risk and greater breast cancer concerns) [7]

Testosterone: Don’t Forget It

Testosterone supports:

· Sexual function

· Mood

· Bone health

· Cardiovascular health [9,10]

Recommended dose: 0.5–1mg daily (cream)

Safety note: Low endometrial risk with transdermal delivery—monitor, but don’t panic. [9]

Woman feeling empowered and healthy after finding appropriate HRT dosing following hysterectomy and oophorectomy

The Bottom Line

Education matters. Having a healthcare practitioner who will do the research for you—who will come up with an individualized solution that helps you feel at home in your body again—is worth its weight in gold.

And it’s absolutely worth pursuing.

You deserve to feel well after surgery. You deserve a provider who believes that. And you deserve HRT doses that are appropriate for your age and your life stage—not doses designed for someone decades older.

Surgical menopause is real. The symptoms are real. And HRT can be safe and effective for endometriosis patients who’ve had hysterectomy/oophorectomy.

The key? Evidence-based dosing, transdermal delivery, and a healthcare provider who will actually do the work to support you.

You deserve that. Don’t settle for less.

Have you had hysterectomy/oophorectomy? Are you struggling with HRT decisions or fighting with a provider who won’t listen? Drop your story in the comments—I want to hear what you’ve experienced.

Need personalized support? Book a free discovery call to chat about your post-surgical nutrition and hormone health with someone who will actually listen.

Health Advice Disclaimer

This content is for educational purposes only and is not medical advice. The information provided is based on peer-reviewed research and general health information. It is not a substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

Every person’s health situation is unique. Before making any changes to your HRT regimen, starting new treatments, or making healthcare decisions, please consult with your doctor, endocrinologist, or qualified healthcare practitioner. They can assess your individual circumstances, medical history, and needs to provide personalized recommendations.

If you experience any concerning symptoms or side effects, seek immediate medical attention from a healthcare professional.

Rebekah Sutton is a nutritionist specializing in chronic illness, neurodivergence, and trauma-informed care. She works with people navigating endometriosis, surgical menopause, and post-surgical recovery.

Book a consultation | Free resources | LinkedIn

References

[1] Saridogan E, Becker CM, Feki A, et al. Management of menopause in women with a history of endometriosis: A clinical consensus guideline from the European Society of Human Reproduction and Embryology and the European Menopause and Andropause Society. Hum Reprod. 2024. PMC11576634.

[2] Manson JE, Aragaki AK, Rossouw JE, et al. The Women’s Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context. Menopause. 2023;30(5):454-461. PMID: 36727752.

[3] Matorras R, Elorriaga MA, Pijoan JI, et al. Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil Steril. 2002;77(2):303-308.

[4] Fedele L, Bianchi S, Raffaelli R, et al. Recurrence of endometriosis after hysterectomy. Fertil Steril. 2015. PMC4286861.

[5] Rovinski D, Ramos RB, Fighera TM, et al. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis. Thromb Res. 2018;168:83-95. PMID: 20601871.

[6] Mohammed K, Abu Dabrh AM, Benkhadra K, et al. Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2015;100(11):4012-4020. PMID: 26544651.

[7] Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Breast and endometrial safety of micronised progesterone in menopausal hormone therapy: a systematic review and meta-analysis. Maturitas. 2025. PMC11499784.

[8] Stanczyk FZ, Hapgood JP, Winer S, Mishell DR Jr. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev. 2013;34(2):171-208.

[9] Davis SR, Baber R, Panay N, et al. The benefits and harms of systemic testosterone therapy in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2019;7(10):754-766. PMC5393495.

[10] Sood R, Shuster LT, Smith R, Vincent A, Jatoi A. Counseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physicians. J Am Board Fam Med. 2011;24(2):202-210.